Insight Molecular Diagnostics Inc Revenue per Employee (IMDX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Insight Molecular Diagnostics Inc   (NASDAQ: IMDX)
 

Insight Molecular Diagnostics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Insight Molecular Diagnostics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 28,793, below the company average number of $59,397.
Within the Healthcare sector Employees of 510 other companies have achieved higher revenue per employee. While Insight Molecular Diagnostics Inc 's total ranking has deteriorated compared to the previous quarter from 2984 to 3474. Insight Molecular Diagnostics Inc has 58 employees.


What is Sales per Employee Ratio?







IMDX Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change -53.86 % -98.5 % -23.35 % 126.09 % 398.08 %
Sales per Employee (TTM) $ 28,793 33,603 69,914 75,897 73,397
IMDX's Total Ranking # 3474 # 2984 # 2882 # 2391 #
Seq. Revenue Change 646.88 % -97.19 % 338.08 % -49.81 % -75.77 %


Revenue per Employee Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 10
Healthcare Sector # 511
Overall Market # 3474

Revenue per Employee Statistics
High Average Low
$ 110,069 $ 59,397 $ 14,207
(Dec 31 2022)   (Sep 30 2024)



Financial Statements
Insight Molecular Diagnostics Inc 's Revenue MRQ $ 0 Millions Visit IMDX's Income Statement
Insight Molecular Diagnostics Inc 's Revenues TTM $ 2 Millions Visit IMDX's aggregate revenue growth
What are IMDX's Sales? Visit IMDX's Sales by Segment




Other Ratios
Insight Molecular Diagnostics Inc 's Income per Employee
Employees in In Vitro & In Vivo Diagnostic Substances
In Vitro & In Vivo Diagnostic Substances Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
IMDX's Revenue per Employee versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for IMDX's Competitors
Revenue per Employee for IMDX's Suppliers
Revenue per Employee for IMDX's Customers

You may also want to know
IMDX's Sales Growth Rates IMDX's Pe Price to earnings ratio IMDX's Receivables Turnover Ratio IMDX's Stock Quote
IMDX's Net Income Growth Rates IMDX's Ps Price to Sales ratio IMDX's Sales per Employee IMDX's Asset Turnover Ratio
IMDX's Net Margin IMDX's Pb Price to Book ratio IMDX's Financial Strength Ratios IMDX's Dividend Payout Ratio
Date modified: 2026-08-12T20:15:19+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Biocorrx Inc   43,701.83 $ 0.787  Million 18 
Femasys Inc   42,581.67 $ 2.299  Million 54 
Dbv Technologies S a   29,517.65 $ 5.018  Million 170 
Addus Homecare Corp  29,128.29 $ 1,475.610  Million 50,659 
Insight Molecular Diagnostics Inc   28,793.10 $ 1.670  Million 58 
Scientific Industries Inc   28,357.43 $ 5.728  Million 202 
Bioadaptives Inc   25,561.00 $ 0.026  Million
Envoy Medical Inc   20,700.00 $ 0.207  Million 10 
Northwest Biotherapeutics Inc  20,695.24 $ 2.173  Million 105 
China Pharma Holdings Inc  17,710.83 $ 3.914  Million 221 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.